Kourosh Parivar, MPharm

Vice President, Head, Clinical Pharmacology, Pfizer Oncology

Kourosh Parivar received his MPharm in 1989 from Uppsala University, Sweden, after which he completed his post-graduate training in pharmacokinetics at the University of California, San Francisco (UCSF). In 1991, after returning to Sweden, he accepted a position as Clinical Research Scientist at the department of Clinical Pharmacology at Astra Arcus AB in Sodertalje, Sweden, and worked with different compounds in the CNS therapeutic area. In 1993, Kourosh joined Pharmacia AB in Stockholm, Sweden, as Clinical Research Manager and worked with the Clinical Pharmacology development of their intravenous anesthetic drug. In 1996, he accepted a position as Clinical Pharmacology Program Leader at Pharmacia & Upjohn AB and was in charge of Clinical Pharmacology development of several compounds for treatment of diabetes and erectile dysfunction. In 1999, Kourosh was appointed as the head of Clinical Pharmacology at Pharmacia & Upjohn AB in Stockholm, Sweden. In 2000, he moved to Singapore on behalf of Pharmacia to set up a Phase I Research clinic which was completed in late 2001. In October 2001, Kourosh was appointed as the head of Clinical Pharmacology at Pharmacia’s R&D facility in Chicago, USA, overseeing the Clinical Pharmacology development of the anti-inflammatory portfolio of Pharmacia. In 2003 Kourosh joined Pfizer as head of Clinical Pharmacology covering antiviral, oncology, diabetes and ophthalmology therapeutic areas. He is currently the head of Clinical Pharmacology of Pfizer Oncology. His areas of interest are quantitative drug development and Clinical Development in Asia.

“This program will provide the students with a variety of skills taught by real life drug developers enabling them to become valuable members of the pharmaceutical research & development community.” – Kourosh